{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:50:41Z","timestamp":1771548641214,"version":"3.50.1"},"reference-count":101,"publisher":"Japan Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1507\/endocrj.ej11-0063","type":"journal-article","created":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T05:20:21Z","timestamp":1311139221000},"page":"613-624","source":"Crossref","is-referenced-by-count":60,"title":["Bone metabolism and fracture risk in type 2 diabetes mellitus [Review]"],"prefix":"10.1507","volume":"58","author":[{"given":"Toru","family":"Yamaguchi","sequence":"first","affiliation":[{"name":"Internal Medicine 1, Shimane University Faculty of Medicine, Shimane 693-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Internal Medicine 1, Shimane University Faculty of Medicine, Shimane 693-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hauschka PV, Lian JB, Cole DE, Gundberg CM (1989) Osteocalcin and matrix protein: vitamin K-dependent proteins in bone. Physiol Rev<\/i> 69: 990-1047.","DOI":"10.1152\/physrev.1989.69.3.990"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Price PA (1989) Gla-containing proteins of bone. Connect Tissue Res<\/i> 21:51-57.","DOI":"10.3109\/03008208909049995"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.05.047"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711119105"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1455"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S, Sugimoto T (2011) Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int<\/i> 22:187-194.","DOI":"10.1007\/s00198-010-1184-7"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.081234"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0270"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pitass AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B (2009) Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab<\/i> 94: 827-832.","DOI":"10.1210\/jc.2008-1422"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1126\/science.1136370"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Smith U (2007) TCF7L2 and type 2 diabetes-we WNT to know. Diabetologia<\/i> 50:5-7.","DOI":"10.1007\/s00125-006-0521-z"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1038\/ng1732"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2007.04.003"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1126\/science.1142382"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1210\/me.2007-0259"},{"issue":"2","key":"16","first-page":"63","volume":"1796","author":"HOOGEBOOM DIANA","year":"2009","ISSN":"https:\/\/id.crossref.org\/issn\/0005-2728","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. DeCarolis NA, Wharton Jr KA, Eisch AJ (2008) Which way does theWntblow? Exploring the duality of canonicalWnt signaling on cellular aging. BioEssays<\/i> 30: 102-106.","DOI":"10.1002\/bies.20709"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Jin T (2008) The WNT signalling pathway and diabetes mellitus. Diabetologia<\/i> 51: 1771-1780.","DOI":"10.1007\/s00125-008-1084-y"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0024"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650080507"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.4.1118"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2009.05.003"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-8-51"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2004.06.008"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T (2009) Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur J Endocrinol<\/i> 160: 265-273.","DOI":"10.1530\/EJE-08-0642"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Inaba M, Terada M, Koyama H, Yoshida O, Ishimura E, Kawagishi T, Okuno Y, Nishizawa Y, Otani S, Morii H (1995) Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cells. J Bone Miner Res<\/i> 10:1050-1056.","DOI":"10.1002\/jbmr.5650100709"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.9.2915"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2187"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int<\/i> 18:427-444.","DOI":"10.1007\/s00198-006-0253-4"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm106"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T (2007) Bone mineral density is not sensitive enough to assess the risk of vertebral fractures in type 2 diabetic women. Calcif Tissue Int<\/i> 80:353-358.","DOI":"10.1007\/s00223-007-9003-7"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.081207"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yamaguchi T, Yamamoto M, Kanazawa I, Yamauchi M, Yano S, Tanaka N, Nitta E, Fukuma A, Uno S, Sho-no T, Sugimoto T (2011) Quantitative ultrasound and vertebral fractures in patients with type 2 diabetes. J Bone Miner Metab<\/i> (Epub ahead of print).","DOI":"10.1007\/s00774-011-0265-9"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.46.1.223"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med<\/i> 318: 1315-1321.","DOI":"10.1056\/NEJM198805193182007"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.621854"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Hernandez CJ, Tang SY, Baumbach BM, Hwu PB, Sakkee AN, van der Ham F, DeGroot J, Bank RA, Keaveny TM (2005) Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone <\/i>37: 825-832.","DOI":"10.1016\/j.bone.2005.07.019"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(01)00697-4"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Takagi M, Kasayama S, Yamamoto T, Motomura T, Hashimoto K, Yamamoto H, Sato B, Okada S, Kishimoto T (1997) Advanced glycation end-products stimulate interleukin-6 production by human bone-derived cells. J Bone Miner Res<\/i> 12: 439-446.","DOI":"10.1359\/jbmr.1997.12.3.439"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Yamamoto T, Ozono K, Miyauchi A, Kasayama S, Kojima Y, Shima M, Okada S (2001) Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy. Am J Kidney Dis<\/i> 38: S161-S164.","DOI":"10.1053\/ajkd.2001.27428"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Katayama Y, Akatsu T, Yamamoto M, Kugai N, Nagata N (1996) Role of nonenzymatic glycosylation of type 1 collagen in diabetic osteopenia. J Bone Miner Res <\/i>11: 931-937.","DOI":"10.1002\/jbmr.5650110709"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Sanguineti R, Storace D, Monacelli F, Federici A, Odetti P (2008) Pentosidine effects on human osteoblasts in vitro. Ann N Y Acad Sci <\/i>1126: 166-172.","DOI":"10.1196\/annals.1433.044"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Ogawa N, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T (2007) The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs. Horm Metab Res<\/i>39: 871-875.","DOI":"10.1055\/s-2007-991157"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Miyata T, Notoya K, Yoshida K, Horie K, Maeda K, Kurokawa K, Taketomi S (1997) Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. J Am Soc Nephrol<\/i> 8: 260-270.","DOI":"10.1681\/ASN.V82260"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.12.107"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Viguet-Carrin S, Roux JP, Arlot ME, Merabet Z, Leeming DJ, Byrjalsen I, Delmas PD, Bouxsein ML (2006) Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone<\/i> 39: 1073-1079.","DOI":"10.1016\/j.bone.2006.05.013"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int<\/i> 21:195-214.","DOI":"10.1007\/s00198-009-1066-z"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Garnero P, Borel O, Gineyts E, Duboeuf F, Solberg H, Bouxsein ML, Christiansen C, Delmas PD (2006) Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone<\/i> 38: 300-309.","DOI":"10.1016\/j.bone.2005.09.014"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Vashishth D (2007) The role of the collagen matrix in skeletal fragility. Curr Osteoporos Rep<\/i> 5: 62-66.","DOI":"10.1007\/s11914-007-0004-2"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Banse X, Sims TJ, Bailey AJ (2002) Mechanical properties of adult vertebral cancellous bone: correlation with collagen intermolecular cross-links. J Bone Miner Res<\/i> 17: 1621-1628.","DOI":"10.1359\/jbmr.2002.17.9.1621"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0155-5"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.41.2.153"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Monnier VM, Sell DR, Nagaraj RH, Miyata S, Grandhee S, Odetti P, Ibrahim SA (1992) Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes<\/i> 41: 36-41.","DOI":"10.2337\/diab.41.2.S36"},{"issue":"18","key":"54","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1016\/S0021-9258(18)99006-X","volume":"266","year":"1991","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"55","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0087-0"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Saito M, Fujii K, Marumo K (2006) Degree of mineralization-related collagen crosslingking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int<\/i> 79: 160-168.","DOI":"10.1007\/s00223-006-0035-1"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Odetti P, Rossi S, Monacelli F, Poggi A, Cirnigliaro M, Federici M, Federici A (2005) Advanced glycation end products and bone loss during aging. Ann NY Acad Sci<\/i> 1043: 710-717.","DOI":"10.1196\/annals.1333.082"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T (2008) Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab<\/i> 93:1013-1019.","DOI":"10.1210\/jc.2007-1270"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold KR, Resnick HE, Tylavsky FA, Black DM, Cummings SR, Harris TB, Bauer DC; for the Health, Aging, and Body Composition Study (2009) Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab<\/i> 94: 2380-2386.","DOI":"10.1210\/jc.2008-2498"},{"key":"60","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-010-0191-2"},{"key":"61","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.44.31740"},{"key":"62","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200111771"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20021371"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ, Jr., Chow WS, Stern D, Schmidt AM (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med<\/i> 4: 1025-1031.","DOI":"10.1038\/2012"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Yamamoto M, Yamaguchi T, Yamauchi M, Sugimoto T (2009) Low serum level of the endogenous secretory receptor for advanced glycation end-products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes. Diabetes Care<\/i> 32: 2263-2268.","DOI":"10.2337\/dc09-0901"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Canalis E (1983) The hormonal and local regulation of bone formation. Endocr Rev<\/i> 4: 62-77.","DOI":"10.1210\/edrv-4-1-62"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Mohan S, Baylink DJ (1991) Bone growth factors. Clin Orthop Relat Res<\/i> 263: 30-48.","DOI":"10.1097\/00003086-199102000-00004"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Ueland T (2004) Bone metabolism in relation to alterations in systemic growth hormone. Growth Horm IGF Res<\/i> 14: 404-417.","DOI":"10.1016\/j.ghir.2004.06.002"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. McCarthy TL, Centrella M, Canalis E (1989) Insulin-like growth factor (IGF) and bone. Connect Tissue Res<\/i> 20: 277-282.","DOI":"10.3109\/03008208909023897"},{"issue":"1","key":"70","first-page":"67","volume":"3","year":"1993","ISSN":"https:\/\/id.crossref.org\/issn\/0956-523X","issn-type":"print"},{"key":"71","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208265200"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Johansson AG, Lindh E, Ljunghall S (1992) Insulin-like growth factor I stimulates bone turnover in osteoporosis. Lancet<\/i> 339: 1619.","DOI":"10.1016\/0140-6736(92)91889-G"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Schwander JC, Hauri C, Zapf J, Froesch ER (1983) Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology<\/i> 113: 297-305.","DOI":"10.1210\/endo-113-1-297"},{"key":"74","doi-asserted-by":"publisher","DOI":"10.1016\/8756-3282(91)90050-S"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D (2002) Circulating levels of IGF-I directly regulate bone growth and density. J Clin Invest<\/i> 110: 771-781.","DOI":"10.1172\/JCI0215463"},{"key":"76","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.8.1272"},{"key":"77","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-005-0163-z"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Thrailkill KM (2002) Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol Ther<\/i> 2: 69-80.","DOI":"10.1089\/152091599316775"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Ahmad T, Ugarph-Morawski A, Lewitt MS, Li J, Saaf M, Brismar K (2008) Diabetic osteopathy and the IGF system in the Goto-Kakizaki rat. Growth Horm IGF Res<\/i> 18: 404-411.","DOI":"10.1016\/j.ghir.2008.02.003"},{"key":"80","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(97)00220-2"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. McCarthy AD, Etcheverry SB, Cortizo AM (2001) Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development. Acta Diabetol<\/i>38: 113-122.","DOI":"10.1007\/s005920170007"},{"key":"82","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0430-0"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Kanazawa I, Yamaguchi T, Sugimoto T (2011) Serum Insulin-like growth factor-I is a maker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporos Int<\/i> 22: 1191-1198.","DOI":"10.1007\/s00198-010-1310-6"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Ali AA, Weinstein RS, Stewart SA, Parfitt AM, Manolagas SC, Jilka RI (2005) Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology<\/i> 146: 1226-1235.","DOI":"10.1210\/en.2004-0735"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Tornvig L, Mosekilde LI, Justesen J, Falk E, Kassem M (2001) Troglitazone treatment increases bone marrow adipose tissue volume but dose not affect trabecular bone volume in mice. Calcif Tissue Int<\/i> 69: 46-50.","DOI":"10.1007\/s002230020018"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung U-i, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H (2004) PPAR-γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest<\/i> 113: 846-855.","DOI":"10.1172\/JCI200419900"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Pei L, Tontonoz P (2004) Fat’s loss is bone’s gain. J Clin Invest<\/i> 113: 805-806.","DOI":"10.1172\/JCI21311"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Soroceau MA, Miao D, Bai X-Y, Su H, Goltzman D, Karaplis AC (2004) Rosiglitazone impacts negatively on bone by promoting osteoblast\/osteocyte apoptosis. J Endocrinol<\/i>183: 203-216.","DOI":"10.1677\/joe.1.05723"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B (2004) Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology<\/i> 145: 401-406.","DOI":"10.1210\/en.2003-0746"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Grey A, Bolland M, Gamble G, Wattie D, Horne A, Davidson J, Reid IR (2007) The peroxisome proliferator-activated receptor-γ agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab<\/i> 92: 1305-1310.","DOI":"10.1210\/jc.2006-2646"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Schwartz AV, Sellmeyer DE, Vittinghoff E, Palermo L, Lecka-Czernik B, Feingold KR, Strotmeyer ES, Resnick HE, Carbone L, Beamer BA, Park SW, Lane NE, Harris TB, Cummings SR (2006) Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab<\/i> 91: 3349-3355.","DOI":"10.1210\/jc.2005-2226"},{"key":"92","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-009-1161-1"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Loke YK, Singh S, Furberg CD (2009) Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ<\/i> 180: 32-39.","DOI":"10.1503\/cmaj.080486"},{"key":"94","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2270"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Schwartz AV (2006) TZDs and bone: a review of the recent clinical evidence. PPAR Res<\/i> 2006: 24502.","DOI":"10.1155\/PPAR\/2006\/24502"},{"key":"96","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-010-0160-9"},{"key":"97","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1999.14.5.821"},{"key":"98","unstructured":"98. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M (1995) Effect of oral adendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med <\/i>333: 1437-1443."},{"key":"99","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1780-5"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. Kanis JA, Oden A, Johansson H, Borgström F, Ström O, McCloskey E (2009) FRAX and its applications to clinical practice. Bone<\/i> 44: 734-743.","DOI":"10.1016\/j.bone.2009.01.373"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, Womack CR, Palermo L, Black DM; Study of Osteoporotic Fractures (SOF) Research Group; Osteoporotic Fractures in Men (MrOS) Research Group; Health, Aging, and Body Composition (Health ABC) Research Group (2011) Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA<\/i> 305: 2184-2192.","DOI":"10.1001\/jama.2011.715"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/8\/58_EJ11-0063\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T10:24:29Z","timestamp":1638095069000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/8\/58_EJ11-0063\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":101,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej11-0063","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}